633 related articles for article (PubMed ID: 19266498)
1. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
[TBL] [Abstract][Full Text] [Related]
2. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
3. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
4. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
5. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses.
Crespo FA; Sun X; Cripps JG; Fernandez-Botran R
J Leukoc Biol; 2006 Mar; 79(3):586-95. PubMed ID: 16415169
[TBL] [Abstract][Full Text] [Related]
6. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
7. A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation.
Bourgeois EA; Levescot A; Diem S; Chauvineau A; Bergès H; Milpied P; Lehuen A; Damotte D; Gombert JM; Schneider E; Girard JP; Gourdy P; Herbelin A
Eur J Immunol; 2011 Feb; 41(2):299-305. PubMed ID: 21268000
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
Page KM; Chaudhary D; Goldman SJ; Kasaian MT
J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766
[TBL] [Abstract][Full Text] [Related]
9. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
[TBL] [Abstract][Full Text] [Related]
10. Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages.
Kubota K
Scand J Immunol; 2010 Mar; 71(3):199-209. PubMed ID: 20415785
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T
Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
[TBL] [Abstract][Full Text] [Related]
13. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
16. Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo.
Oki S; Tomi C; Yamamura T; Miyake S
Int Immunol; 2005 Dec; 17(12):1619-29. PubMed ID: 16291659
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
Santarelli L; Bracci M; Mocchegiani E
Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
[TBL] [Abstract][Full Text] [Related]
18. Murine NKT cells produce Th17 cytokine interleukin-22.
Goto M; Murakawa M; Kadoshima-Yamaoka K; Tanaka Y; Nagahira K; Fukuda Y; Nishimura T
Cell Immunol; 2009; 254(2):81-4. PubMed ID: 19010461
[TBL] [Abstract][Full Text] [Related]
19. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
Byrne P; McGuirk P; Todryk S; Mills KH
Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
[TBL] [Abstract][Full Text] [Related]
20. IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema.
Lind SM; Kuylenstierna C; Moll M; D Jordö E; Winqvist O; Lundeberg L; Karlsson MA; T Linder M; Johansson C; Scheynius A; Sandberg JK; Karlsson MC
Eur J Immunol; 2009 Aug; 39(8):2293-301. PubMed ID: 19637196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]